Myriad Genetics to Present at Two Upcoming Healthcare Conferences
Apr 27, 2018 11:10 am UTC| Business
SALT LAKE CITY, April 27, 2018 -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled to present at two...
Super Absorbent Polymers Market to Reach US$ 8,173.1 mn by 2025 – Persistence Market Research
Apr 27, 2018 11:07 am UTC| Business
New York, April 27, 2018 -- The global superabsorbent polymer market is choc-o-bloc with companies both small and large. However, the market features a largely consolidated vendor landscape with top three players...
Apr 27, 2018 11:05 am UTC| Business
SALT LAKE CITY, April 27, 2018 -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that results from a large prospective process-intervention study that...
Golar LNG Partners LP Cash Distributions
Apr 27, 2018 11:02 am UTC| Business
Golar LNG Partners LP ("the Partnership") (NASDAQ: GMLP) announced today that its board of directors has approved a quarterly cash distribution with respect to the quarter ended March 31, 2018 of $0.5775 per common and...
Advantagene Announces Clinical Trial Collaboration
Apr 27, 2018 11:00 am UTC| Business
AUBURNDALE, Mass., April 27, 2018 -- Advantagene, Inc. today announced that the company entered into a clinical trial collaboration with Bristol-Myers Squibb (NYSE:BMY) to evaluate the safety, tolerability, and...
uniQure Announces to Present at Multiple Conferences in May
Apr 27, 2018 11:00 am UTC| Business
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, April 27, 2018 -- uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy, today announced that it will be featured in multiple presentations at upcoming medical and...
Apr 27, 2018 11:00 am UTC| Business
FREMONT, Calif., April 27, 2018 -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions associated with demyelination...